Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

Issue 1-2/2009

Content (10 Articles)

Chronic Leukemia

Treatment of Hematologic Neoplasms with New Immunomodulatory Drugs (IMiDs)

Peter H. Wiernik

Chronic Leukemia

Chronic Lymphocytic Leukemia: New Concepts and Emerging Therapies

Tahamtan Ahmadi, Tapan Maniar, Stephen Schuster, Edward Stadtmauer

Gynecologic Tumors

Role of Robotic Surgery in Endometrial Cancer

Paul S. Lin, Mark T. Wakabayashi, Ernest S. Han

Gynecologic Tumors

Worldwide Impact of the Human Papillomavirus Vaccine

Amy A. Hakim, Tri A. Dinh

Gynecologic Tumors

Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer

Ernest S. Han, Paul Lin, Mark Wakabayashi

Gynecologic Tumors

Current Understanding of Risk Factors for Ovarian Cancer

Thanasak Sueblinvong, Michael E. Carney

Open Access Bone Cancer

The Multidisciplinary Management of Osteosarcoma

Noah Federman, Nicholas Bernthal, Fritz C. Eilber, William D. Tap

Bone Cancer

The Clinical Management of Chondrosarcoma

Richard F. Riedel, Nicole Larrier, Leslie Dodd, David Kirsch, Salutario Martinez, Brian E. Brigman

Bone Cancer

Multidisciplinary Management of Primary Tumors of the Vertebral Column

Wesley Hsu, Thomas A. Kosztowski, Hasan A. Zaidi, Michael Dorsi, Ziya L. Gokaslan, Jean-Paul Wolinsky

Bone Cancer

Ewing’s Sarcoma: Standard and Experimental Treatment Options

Vivek Subbiah, Pete Anderson, Alexander J. Lazar, Emily Burdett, Kevin Raymond, Joseph A. Ludwig

Dec 08
Issue: Special Issue 2/2008
Aug 09
Issue: 3-4/2009

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits